P3.12.31 Rezivertinib in Advanced NSCLC Patients With EGFR T790M Mutation via Tissue/Plasma Samples: Pooled Analysis of 2 Clinical Studies
0Citations signalées, ce qui n’est pas une note de qualité
46Institutions déclarées
2Pays d’affiliation déclarés
Rattachement africain : cn, us. Niveau de preuve : code pays fourni par la source.
Résumé indisponible. Les résultats de l’étude ne doivent pas être déduits de son seul titre.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- P3.12.31 Rezivertinib in Advanced NSCLC Patients With EGFR T790M Mutation via Tissue/Plasma Samples: Pooled Analysis of 2 Clinical Studies
- Date Crossref
- 01/10/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Henan Cancer HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeNational Clinical ResearchHarbin Medical UniversityThird Affiliated Hospital of Harbin Medical UniversityShanxi Medical UniversityFirst Hospital of Shanxi Medical UniversityFirst Affiliated Hospital of Zhengzhou UniversityPeking UniversityPeking University Cancer HospitalXinjiang Medical UniversityTumor Hospital of Xinjiang Medical UniversityChongqing UniversityChongqing Cancer HospitalSichuan UniversityWest China Hospital of Sichuan UniversityJinan Central HospitalShandong First Medical UniversityZhejiang Cancer HospitalArmy Medical UniversityXinqiao HospitalUniversity of Chinese Academy of SciencesFirst Affiliated Hospital Zhejiang UniversityDalian Medical UniversityFirst Affiliated Hospital of Dalian Medical UniversityYuhuangding HospitalFirst Affiliated Hospital of Bengbu Medical CollegeHenan Provincial People's HospitalUniversity of Science and Technology of ChinaFuyang City People's HospitalDeyang Stomatological HospitalGuangdong Medical CollegeAffiliated Hospital of Guangdong Medical College HospitalSoochow UniversityFirst Affiliated Hospital of Soochow UniversityHebei Medical UniversityXingtai People's HospitalCentral South UniversityThird Xiangya HospitalFirst Affiliated Hospital of Henan University of Science and TechnologyJiangsu Province HospitalHandan CollegeChinese PLA General HospitalSecond Affiliated Hospital of Soochow UniversityCrystal Pharmatech (United States)Fosun Pharma (China)
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesGastric Cancer Management and Outcomes